Amarin Corp Plc (AMRN)

[sts66]

EVAPORATE is under attack as well - right before the ESC conf. too - this was published in the ESC's "European Heart Journal", equivalent to our AHA journal:

https://academic.oup.com/eurheartj/article/42/31/3023/6273098?login=true

Underlying mechanisms involved in the icosapent ethyl reduction of cardiovascular events still cannot be attributed to an anti-atherosclerotic effect

Read all of it - they accuse Budhoff for manipulating the randomization process, impugn his scientific integrity, and claim he didn't run the trial correctly. Again I ask who is behind these constant attacks on V research and what do they have to gain by discrediting AMRN and V?